Laboratory Developed Test Industry Trends: What to Know and Prepare for

The laboratory developed test (LDT) market has rapidly evolved into one of the most pivotal segments within the broader diagnostics and life sciences landscape. As healthcare systems increasingly shift toward personalized medicine, rapid diagnostics, and decentralized testing, LDTs have become a cornerstone of innovation and flexibility. These tests, developed and used within a single laboratory, often fill gaps left by commercially available diagnostic tools. In 2025, the LDT economy is witnessing accelerated growth fueled by a mix of technological advances, evolving regulations, and heightened demand across medical specialties. Let’s explore the seven major trends driving the laboratory developed test economy in 2025. The global market for Laboratory Developed Test is estimated to grow from US$ 9.0 Bn in 2025 to US$ 13.9 Bn in 2032 at a CAGR of 6.4% over the forecast period. As assessed by Persistence Market Research, clinical biochemistry tests are expected to account for a market value share of 34.2% by 2032. Precision Medicine and Tailored Diagnostics A central trend influencing the LDT economy is the expanding reach of precision medicine. Healthcare providers are seeking diagnostic tools that can be customized for individual patient profiles. LDTs offer an agile solution—allowing laboratories to develop tests tailored to specific genetic markers, tumor profiles, or rare diseases. In oncology, infectious disease, and pharmacogenomics, LDTs are increasingly becoming the go-to choice for clinicians who require fast, accurate, and patient-specific diagnostic